Moreover, DNR, vincristine (VCR), etoposide (VP-16), cytosine arabinoside (Ara-C), adriamycin (ADM), and ATO can increase HMGB1 expression and promote chemoresistance in hematological malignancies [22, 44]. The gene discussed is HMGB1; the disease is hematologic disorder.